Improved survival for stage IV melanoma from an unknown primary site (Q37280728)

19 August 2017

Improved survival for stage IV melanoma from an unknown primary site (English)

1 reference

19 August 2017

4

Donald L Morton

1 reference

19 August 2017

Chris C Lee

1

1 reference

19 August 2017

Mark B Faries

series ordinal

2

1 reference

19 August 2017

Leslie A Wanek

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

18 May 2009

1 reference

Journal of Clinical Oncology

19 August 2017

1 reference

19 August 2017

27

1 reference

19 August 2017

21

1 reference

19 August 2017

3489-3495

1 reference

19 August 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

A single-institution validation of the AJCC staging system for stage IV melanoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Age and gender are significant independent predictors of survival in primary cutaneous melanoma.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Prognostic factors in 1,521 melanoma patients with distant metastases.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Malignant melanoma primary in lymph node. The case of the missing link.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Histological regression in primary cutaneous melanoma: recognition, prevalence and significance

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Cutaneous melanoma: prognosis and treatment results worldwide

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Malignant melanoma: the patient with an unknown site of primary origin.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Occult primary malignant melanoma: Factors influencing survival

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Survival of patients with visceral metastatic melanoma from an occult primary lesion: a retrospective matched cohort study.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Autonomous histopathological regression of primary tumours associated with specific immune responses to cancer antigens

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717755

Metastatic malignant melanoma with an unknown primary

20 October 2018

1 reference

12 December 2020

Treatment of unknown primary melanoma

1 reference

12 December 2020

Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group

1 reference

12 December 2020

Primary melanoma tumour regression associated with an immune response to the tumour-associated antigen melan-A/MART-1

1 reference

12 December 2020

Spontaneous regression of malignant melanoma. Pathologic and immunologic study in a ten year survivor

1 reference

12 December 2020

Immunologic aspects of unknown primary melanoma

1 reference

12 December 2020

Clinical aspects of unknown primary melanoma

1 reference

12 December 2020

Metastatic melanoma of unknown primary

1 reference

12 December 2020

Malignant melanoma with unknown primary site

1 reference

12 December 2020

End results in the treatment of malignant melanoma; a report of 1190 cases

1 reference

12 December 2020

MALIGNANT MELANOMA OF UNKNOWN PRIMARY ORIGIN

1 reference

12 December 2020

Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?

1 reference

12 December 2020

Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients

1 reference

12 December 2020

Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma

1 reference

12 December 2020

Changing biology of cutaneous melanoma

1 reference

12 December 2020

Melanoma from unknown primary site and amelanotic melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2008.18.9845

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19451446

1 reference